trial · primary record
cyclophosphamide
Malignant Pleural Mesothelioma (MPM)
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2027-09-30 |
| Primary endpoint | MTD of M28z1XXPD1DNR |
| Registry ID | NCT04577326 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:48.495Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04577326
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- CYCLOPHOSPHAMIDE · approval
- CYCLOPHOSPHAMIDE · approval
- Cyclophosphamide · compound